1-4 of 4
Inger Margulies
Close
Sort by
Journal Articles

A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity

John E. Weldon, Laiman Xiang, Oleg Chertov, Inger Margulies, Robert J. Kreitman, David J. FitzGerald, Ira Pastan
Journal: Blood
Blood (2009) 113 (16): 3792–3800.
https://doi.org/10.1182/blood-2008-08-173195
Published: 2009
Journal Articles

Molecular Characteristic of Variant and Classic Hairy Cell Leukemia.

Evgeny Arons, PhD, Tara Suntum, Joel Sunshine, Anna Orthwein, Inger Margulies, Maryalice Stetler-Stevenson, MD, PhD, Robert Kreitman, MD
Journal: Blood
Blood (2008) 112 (11): 1063.
https://doi.org/10.1182/blood.V112.11.1063.1063
Published: 2008
Journal Articles

Soluble CD22 as a tumor marker for hairy cell leukemia

Clinical Trials & Observations
Kakushi Matsushita, Inger Margulies, Masanori Onda, Satoshi Nagata, Maryalice Stetler-Stevenson, Robert J. Kreitman
Journal: Blood
Blood (2008) 112 (6): 2272–2277.
https://doi.org/10.1182/blood-2008-01-131987
Published: 2008
Journal Articles

Responses in Refractory Hairy Cell Leukemia to a Recombinant Immunotoxin

Robert J. Kreitman, Wyndham H. Wilson, David Robbins, Inger Margulies, Maryalice Stetler-Stevenson, Thomas A. Waldmann, Ira Pastan
Journal: Blood
Blood (1999) 94 (10): 3340–3348.
https://doi.org/10.1182/blood.V94.10.3340.422k19_3340_3348
Published: 1999